A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2006
11/09/2006	US20060251675 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
11/09/2006	US20060251674 Formulations and process for production of Bordetella bronchiseptica P68 antigen and vaccines
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251670 Multiple variants of meningococcal protein nmb1870
11/09/2006	US20060251669 Recombinant copper containing protein for use in prevention and treatment of parasitic infection
11/09/2006	US20060251668 Tumor-specific recognition molecules
11/09/2006	US20060251667 Recombinant nucleic acid useful for inducing protective immune response against allergens
11/09/2006	US20060251666 Cancer antigens and utilization thereof
11/09/2006	US20060251665 Vaccines
11/09/2006	US20060251664 Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
11/09/2006	US20060251663 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability
11/09/2006	US20060251662 diagnosing the presence of a multiple myeloma tumor in a mammal; antitumor agents; identify polypeptides, cell membrane-associated, secreted or intracellular polypeptides whose expression is specifically limited to only a single (or very limited number of different) tissue type(s)
11/09/2006	US20060251661 Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal Antibody Binding
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251659 Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity
11/09/2006	US20060251658 Antibodies to TGF-beta
11/09/2006	US20060251657 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases
11/09/2006	US20060251656 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies
11/09/2006	US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006	US20060251654 Method for treatment of malignant and infectious chronic diseases
11/09/2006	US20060251653 Methods for treating interleukin-6 related diseases
11/09/2006	US20060251652 Containing light and heavy chain variable regions with fully human germline frameworks; high binding affinity, and low dissociation rate; anticarcinogenic agents; Non-Hodgkin's lymphoma, Waldenstrom's macroglobulinemia
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251650 Preventing angiogenesis by administering an antibody, or fragment, that specifically binds an extracellular domain of a neuropilin receptor; inhibiting endothelial growth factors (VEGF) from binding to the receptor; anticarcinogenic and antimetastasis agents
11/09/2006	US20060251649 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251647 Quantitating the level of Apo-2 receptor expression in a biological sample to determine whether a patient has a disorder associated with an abnormal rate of apoptotic cell death
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251645 Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
11/09/2006	US20060251644 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
11/09/2006	US20060251623 Packaged virus-like particles
11/09/2006	US20060251617 Methods for treating lymphomas
11/09/2006	US20060251579 Medicament for the two-step perioperative therapy of solid tumours
11/09/2006	DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
11/09/2006	CA2821389A1 Novel method for preventing or treating m tuberculosis infection
11/09/2006	CA2609561A1 Polypeptide, vaccine and use thereof
11/09/2006	CA2607715A1 Novel method for preventing or treating m tuberculosis infection
11/09/2006	CA2607341A1 Diagnosis and treatment of endometriosis
11/09/2006	CA2607327A1 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
11/09/2006	CA2607234A1 Method for identifying modulators of noah10 useful for treating alzheimer's disease
11/09/2006	CA2606803A1 Disease therapy using dying or dead cells
11/09/2006	CA2606506A1 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	CA2606378A1 Fcrn antibodies and uses thereof
11/09/2006	CA2606341A1 Genemap of the human genes associated with crohn's disease
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2606105A1 Preparation of soluble n-protein/truncated p-protein complexes or n-proteins soluble in a virus of the paramyxoviridae family and use thereof in vaccines
11/09/2006	CA2595277A1 Method for diagnosing multiple sclerosis
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719528A2 Compositions and methods for treatment of angiogenesis in pathological lesions
11/08/2006	EP1719520A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use
11/08/2006	EP1718979A2 Methods of screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis
11/08/2006	EP1718974A2 Method of evaluating the therapeutic potential of a vaccine for mucosal administration
11/08/2006	EP1718767A2 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
11/08/2006	EP1718750A1 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof
11/08/2006	EP1718749A1 Humanized antibody
11/08/2006	EP1718737A1 Cancerous disease modifying antibodies
11/08/2006	EP1718736A1 Cancerous disease modifying antibodies
11/08/2006	EP1718669A1 Identification of novel ige epitopes
11/08/2006	EP1718335A2 Drug conjugates
11/08/2006	EP1718334A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
11/08/2006	EP1718333A2 Methods of modulating cd200 and cd200r
11/08/2006	EP1718332A1 Method for inhibiting the transendothelial migration of cells such as leukocytes or tumor cells by a cd-81 binding subsance and uses thereof
11/08/2006	EP1718331A1 Methods and compositions for dosing of allergens
11/08/2006	EP1718330A2 Complexed polypeptide and adjuvant for improved vaccines
11/08/2006	EP1718329A2 Methods of treating skin disorders
11/08/2006	EP1718321A2 Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein
11/08/2006	EP1718310A2 Methods and compositions for treating tumors and metastatic disease
11/08/2006	EP1718238A1 Isolated plasma and method for hyperimmunisation and plasma collection
11/08/2006	EP1265920B1 Angiogenesis-associated proteins, and nucleic acids encoding the same
11/08/2006	EP1237930B1 Chimeric amyloid beta peptides
11/08/2006	CN1860132A Inhibitors of extracellular hsp90
11/08/2006	CN1860130A New soluble and stabilized trimeric form of GP41 polypeptides
11/08/2006	CN1859926A Polymer encapsulation of adenoviruses
11/08/2006	CN1859923A Optimized expression of hpv 45 l1 in yeast
11/08/2006	CN1859851A Mesothelin vaccines and model systems
11/08/2006	CN1858064A Chicken yoke antibody resisting Bengalese cobra venom and its preparation
11/08/2006	CN1858059A Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use
11/08/2006	CN1283801C Protein expression in baculovirus vector expression system
11/08/2006	CN1283798C Polypeptides and polynucleotides from coagulase-negative staphylocoui
11/08/2006	CN1283789C Aike 30 Virus and its use
11/08/2006	CN1283788C Recombination pseudorabies virus for expressing pig breeding and respiration comproehensive oyndrome virus and application
11/08/2006	CN1283663C Antithemolytic streptococcus, staphylococcus and candida albicans lgY antibody and preparation thereof
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283652C Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
11/08/2006	CN1283316C Attenuated live vaccine of vibrion from eel
11/08/2006	CN1283315C Bovine respiratory coronavirus as a vaccine
11/07/2006	US7132554 Synergistic mixture of an orally administered taxane compound and the epidermal growth factor receptor antibody, cetuximab; especially for treaing colorectal cancer, breast cancer, gastric cancer, ovarian cancer, non-small cell lung cancer and cancers of the head and neck.
11/07/2006	US7132512 Medicament for the treatment of chlamydial infection
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132510 Chimeric protein comprising immunogenic domains for directed targeting of tumor cells; immunotherapy; antitumor agents
11/07/2006	US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006	US7132407 N'-neu-IL-2 fusion gene controlled by a cytomegalo virus promoter
11/07/2006	US7132406 Stimulation of cellular regeneration and differentiation in the inner ear
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132291 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/07/2006	US7132281 Methods and host cells for producing human monoclonal antibodies to CTLA-4
11/07/2006	US7132280 Genetically engineered cell for use in the generation of vaccines against bacterial and viral infections
11/07/2006	US7132271 Methods for enhancing the production of viral vaccines in cell culture

1 ... 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 ... 1823